logo

Corcept Therapeutics Inc (CORT)



Trade CORT now with
  Date
  Headline
3/6/2017 8:33:12 AM Corcept Therapeutics Q4 Revenue Of $23.8 Mln, A 59% Increase
1/30/2017 4:26:56 PM Corcept Therapeutics Q4 GAAP EPS $0.04 Vs $0.01 Last Year; Revenue Up 59% To $23.8 Mln
12/10/2016 8:49:12 PM Corcept Therapeutics: Results Of Mifepristone Plus Eribulin Trial Encouraging